These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8088239

  • 1. [Subsequent manic disorder due to combination vigabatrin-clomipramine].
    Sastre-Garau P, Thomas P, Beaussart M, Goudemand M.
    Encephale; 1994; 20(3):363. PubMed ID: 8088239
    [No Abstract] [Full Text] [Related]

  • 2. [Subsequent manic onset caused by association of vigabatrin-clomipramine].
    Sastre-Garau P, Thomas P, Beaussart M, Goudemand M.
    Encephale; 1993; 19(4):351-2. PubMed ID: 8275923
    [No Abstract] [Full Text] [Related]

  • 3. [Drug-resistant epilepsy].
    Arroyo S, Rumiá J, Martínez I, Ribalta T.
    Rev Neurol; 1998 Nov; 27(159):867-71. PubMed ID: 9859169
    [No Abstract] [Full Text] [Related]

  • 4. Vigabatrin and complex partial status.
    Arzimanoglou A.
    Seizure; 1994 Mar; 3(1):79-80. PubMed ID: 8044458
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions.
    Wilson EA, Brodie MJ.
    BMJ; 1997 Jun 07; 314(7095):1693. PubMed ID: 9193311
    [No Abstract] [Full Text] [Related]

  • 8. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F, Sopranzi N.
    Clin Ter; 1998 Jun 07; 149(2):131-4. PubMed ID: 9780478
    [Abstract] [Full Text] [Related]

  • 9. Vigabatrin.
    Calli J, Farrington E.
    Pediatr Nurs; 1998 Jun 07; 24(4):357-61. PubMed ID: 9849270
    [No Abstract] [Full Text] [Related]

  • 10. Vigabatrin aggravates absences and absence status.
    Cocito L, Primavera A.
    Neurology; 1998 Nov 07; 51(5):1519-20. PubMed ID: 9818915
    [No Abstract] [Full Text] [Related]

  • 11. The irreversible gamma-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome.
    Stuppaeck CH, Deisenhammer EA, Kurz M, Whitworth AB, Hinterhuber H.
    Alcohol Alcohol; 1996 Jan 07; 31(1):109-11. PubMed ID: 8672169
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vigabatrin and psychosis: is there a true correlation?
    Veggiotti P, De Agostini G, Baldi PL, Muzio C, Lanzi G.
    Acta Neurol Scand; 1997 Mar 07; 95(3):189-90. PubMed ID: 9088390
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aminoaciduria resulting from vigabatrin administration in children with epilepsy.
    Lahat E, Ben-Zeev B, Zlotnik J, Sela BA.
    Pediatr Neurol; 1999 Jul 07; 21(1):460-3. PubMed ID: 10428431
    [Abstract] [Full Text] [Related]

  • 18. Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent.
    Wong IC, Mawer GE, Sander JW.
    BMJ; 1997 Jun 07; 314(7095):1693-4. PubMed ID: 9193312
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vigabatrin and multifocal myoclonus in adults with partial seizures.
    Neufeld MY, Vishnevska S.
    Clin Neuropharmacol; 1995 Jun 07; 18(3):280-3. PubMed ID: 8635188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.